"코로나19 '초기' 치료의 길 열리나"...美 파우치, '인터페론 치료법'에 주목'' 

'英 시네어젠·美 머크·加 일라이릴리' 등 인터페론 기반 치료제 보유 
코로나19, 세포 내 '인터페론' 생성 방해해 면역반응 차단...중증 발전 

***에이프로젠제약, ‘인터페론’ 건강보험 적용 소식 급등 



www.hankyung.com/international/article/2020072093537 

[특징주] 에이프로젠제약, ‘인터페론’ 건강보험 적용 소식에 강세 

http://www.seoulwire.com/news/articleView.html?idxno=269831